UroToday - Bladder Cancer

Home

Bladder Cancer

UroToday's Bladder Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of bladder cancer. Also available are conference coverage for all timely bladder cancer science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Display

results per page

Results 351 - 400 of 1748

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Squamous Cell Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Study of 16 Cases - Abstract
Monday, 15 June 2009
Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA.
read more

Bladder Cancer Clusters in Florida: Identifying Populations at Risk - Abstract
Friday, 12 June 2009
Division of Urology, Columbia University, Mount Sinai Medical Center, Miami Beach and Department of Epidemiology and Public Health, University of Miami Miller School of Medicine, Miami, Florida.
read more

Patterns of Use of Systemic Chemotherapy for Medicare Beneficiaries with Urothelial Bladder Cancer - Abstract
Friday, 12 June 2009
University of Washington Department of Urology, VA Puget Sound Health Care System, Seattle, WA 98195, USA.
read more

Strategies to Enhance the Efficacy of Intravescical Therapy for Non-Muscle Invasive Bladder Cancer - Abstract
Friday, 12 June 2009
Department of Urology, University of Pittsburgh School of Medicine Pittsburgh, PA, USA.
read more

Multiple Adverse Histological Features Increase the Odds of Under Staging T1 Bladder Cancer - Abstract
Thursday, 11 June 2009
Department of Urology, University of Michigan, Ann Arbor, Michigan.
read more

A Critical Role for Choline Kinase-Alpha in the Aggressiveness of Bladder Carcinomas - Abstract
Thursday, 11 June 2009
Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
read more

Bladder Cancer Screening in a High Risk Asymptomatic Population Using a Point of Care Urine Based Protein Tumor Marker - Abstract
Thursday, 11 June 2009
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas.
read more

Beyond the Abstract - The Use of Short Tandem Repeat Profiling to Characterize Human Bladder Cancer Cell Lines
Wednesday, 10 June 2009
BERKELEY, CA (UroToday.com) - My laboratory established a series of urothelial cancer cell lines at the University of Michigan.
Login to read more...

Associations Between Comorbidity, and Overall Survival and Bladder Cancer Specific Survival After Radical Cystectomy: Results From the Alberta Urology Institute Radical Cystectomy Database - Abstract
Wednesday, 10 June 2009
Division of Urology, Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta Canada.
read more

Predictive Value of Combined Immunohistochemical Markers in Patients With pT1 Urothelial Carcinoma at Radical Cystectomy - Abstract
Wednesday, 10 June 2009
Division of Urology, Sidney Kimmel Center for Prostate and Urologic Cancer, Memorial Sloan-Kettering Cancer Center, New York, New York.
read more

A Population Based Assessment of Perioperative Mortality After Cystectomy for Bladder Cancer - Abstract
Wednesday, 10 June 2009
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada.
read more

Evidence for Toxicity Differences Between Inorganic Arsenite and Thioarsenicals in Human Bladder Cancer Cells - Abstract
Tuesday, 09 June 2009
Analytical and Environmental Toxicology, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada T6G 2G3.
read more

Tumor Detection and Serosal Invasion of Bladder Cancer: Role of Three-Dimensional Volumetric Reconstructed US - Abstract
Tuesday, 09 June 2009
Department of Radiology, Soonchunhyang University Hospital, Seoul, Korea.
read more

Chromosomal Imbalance in the Progression of High-Risk Non-Muscle Invasive Bladder Cancer - Abstract
Tuesday, 09 June 2009
Non-muscle invasive bladder neoplasms with invasion of the lamina propria (stage T1) or high grade of dysplasia are at "high risk" of progression to life-threatening cancer.
read more

A Lower Risk of Dying from Urological Cancer in Down Syndrome: Clue for Cancer Protecting Genes on Chromosome 21 - Abstract
Tuesday, 09 June 2009
Laboratoire d'Anatomie Pathologique, Centre Hospitalier, Tulle, France.
read more

Hexylaminolevulinate Photodynamic Diagnosis for Multifocal Recurrent Nonmuscle Invasive Bladder Cancer - Abstract
Tuesday, 09 June 2009
The Urology Centre, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
read more

DNA Repair Genotype Interacts with Arsenic Exposure to Increase Bladder Cancer Risk - Abstract
Monday, 08 June 2009
Department of Community & Family Medicine, Section of Biostatistics & Epidemiology, Dartmouth Medical School, Lebanon, NH 03756, United States.
read more

Twenty-Year Experience of Radical Cystectomy for Bladder Cancer in a Medium-Volume Centre - Abstract
Friday, 05 June 2009
To evaluate long-term survival after radical cystectomy (RC) for bladder cancer (BC) and to define risk factors for BC-specific death.
read more

Efficacy of Bacille Calmette-Guérin Immunotherapy Predicted by Expression of Antigen-presenting Molecules and Chemokines - Abstract
Friday, 05 June 2009
Departamento de Imunologia, Faculdade de Ciências Médicas de Lisboa, Lisboa, Portugal.
read more

Synergistic Antitumor Effects of Fleroxacin With 5-fluorouracil In Vitro and In Vivo for Bladder Cancer Cell Lines - Abstract
Friday, 05 June 2009
Division of Urology, Rinku General Medical Center, Izumisano Municipal Hospital, Izumisano City, Osaka, Japan.
read more

Podcast - A Report from the Fire Departments Instructors Conference (FDIC), The Largest Gathering of Firefighters in North America
Friday, 05 June 2009

Login to read more...

Podcast - Veterans’ Health: Bladder Cancer Diagnosis and Surveillance
Friday, 05 June 2009

Login to read more...

Men's Health Month: Recognize Your Individual Risk for Bladder Cancer
Thursday, 04 June 2009
BERKELEY, CA, USA (News Release) - June 4, 2009 June is Men's Health Month. Bladder Cancer is more prevalent in men, especially military veterans, firefighters and cigarette smokers.
read more

Impact of Treatment Delay in Patients with Bladder Cancer Managed with Partial Cystectomy in Quebec: A Population-Based Study - Abstract
Thursday, 04 June 2009
Department of Surgery (Urology), McGill University, Montréal, Que.
read more

Differential Effects of MAPKs Signaling on the Growth of Invasive Bladder Cancer Cells - Abstract
Thursday, 04 June 2009
Signal transduction and Molecular Urology Laboratory, Program in Urosciences, Division of Urology, Department of Surgery, School of Medicine, University of Colorado at Denver and Health Sciences Center, Aurora, CO 80045, USA.
read more

A Population-Based Study of Patterns of Care for Muscle-Invasive Bladder Cancer in Sweden - Abstract
Thursday, 04 June 2009
Department of Urology, University Hospital, Linkoping, Sweden.
read more

Podcast - "Ask the Expert" - Military Veterans and Firefighters Have Been Identified at Increased Risk for Bladder Cancer. Please Compare and Contrast the Risk Factors Effecting These Patient Populations
Thursday, 04 June 2009
Barry S. Stein, MD Question: Military veterans and firefighters have been identified at increased risk for bladder cancer. Please compare and contrast the risk factors effecting these patient populations. Dr. Barry Stein: “The two groups are really very different. Military veterans have an increased incidence of bladder cancer primarily because they have a high incidence of smoking. This is especially true of Viet Nam veterans since I work at a VA hospital, I see a very high incidence of bladder cancer. “ Firefighters may not need to be cigarette smokers to be at increased incidence of bladder cancer. They may be seeing toxic chemicals in the fumes in the fires they are fighting.”
Login to read more...

ASCO 2009 - A Multicenter Phase II Study of Cisplatin, Gemcitabine, and Bevacizumab as First-Line Chemotherapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU-0475 - Session Highlights
Wednesday, 03 June 2009
ORLANDO, FL, USA (UroToday.com) - This study investigated the addition of bevacizumab to the standard regimen of cisplatin/gemcitabine as first-line therapy for patients with metastatic urothelial carcinoma (UC).
Login to read more...

ASCO 2009 - Randomized Trial of p53 Targeted Adjuvant Therapy for Patients with Organ-Confined Node-Negative Urothelial Bladder Cancer - Session Highlights
Wednesday, 03 June 2009
ORLANDO, FL, USA (UroToday.com) - Studies have suggested a prognostic role for p53 in patients with urothelial carcinoma (UC) of the bladder.
Login to read more...

Join Men's Health Network In Celebration of Men's Health Month
Wednesday, 03 June 2009
WASHINGTON, DC, USA (Press Release) - May 29, 2009
read more

Beyond the Abstract - Urinary Bladder Cancer: Diffusion-Weighted MR Imaging--Accuracy for Diagnosing T Stage and Estimating Histologic Grade
Wednesday, 03 June 2009
BERKELEY, CA (UroToday.com) - The usefulness of diffusion-weighted imaging (DWI) for depicting malignant tumors and an apparent diffusion coefficient (ADC) value for characterizing the grade of tumor has been suggested recently.
Login to read more...

An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non-Muscle-Invasive Bladder Cancer - Abstract
Wednesday, 03 June 2009
Uppsala University Hospital, Department of Urology, Uppsala, Sweden.
read more

Neobladder Reconstruction Following Radical Cystoprostatectomy for Invasive Bladder Cancer - Abstract
Wednesday, 03 June 2009
Department of Urology, University of Miami School of Medicine, Miami, FL, USA.
read more

ASCO 2009 - A Single Institution Experience with Induction and Maintenance Intravesical Docetaxel in the Management of Non-Muscle-Invasive Bladder Cancer Refractory to BCG Therapy - Session Highlights
Tuesday, 02 June 2009
ORLANDO, FL, USA (UroToday.com) - An initial Phase I trial of intravesical docetaxel treatment for patients with non-muscle-invasive bladder cancer demonstrated impressive initial response rates, but disappointing durability.
Login to read more...

ASCO 2009 - Ethnic Differences in Bladder Cancer Survival - Session Highlights
Tuesday, 02 June 2009
ORLANDO, FL, USA (UroToday.com) - As with many other cancers, racial disparities in bladder cancer have demonstrated poorer outcomes for African Americans.
Login to read more...

ASCO 2009 - Prognostic Risk Group Classification for Patients with Platinum-Refractory Metastatic Urothelial Cancer Treated with Second-Line Chemotherapy - Session Highlights
Tuesday, 02 June 2009
ORLANDO, FL, USA (UroToday.com) - Second-line chemotherapy agents for patients with platinum-refractory metastatic urothelial cancer (UC) are associated with low response rated and short progression-free and overall survival rates.
Login to read more...

ASCO 2009 - Adjuvant Chemotherapy for High-Risk Upper Tract Urothelial Carcinoma: Results from the Upper Tract Urothelial Carcinoma Collaboration - Session Highlights
Tuesday, 02 June 2009
ORLANDO, FL, USA (UroToday.com) - Little evidence exists regarding the use of adjuvant chemotherapy following radical nephroureterectomy for the management of patients with upper tract urothelial carcinoma (UTUC).
Login to read more...

ASCO 2009 - Vascular Thromboembolic Events in Patients with Advanced Urothelial Cancer Treated with Carboplatin/Gemcitabine Alone or in Combination with Bevacizumab - Session Highlights
Tuesday, 02 June 2009
ORLANDO, FL, USA (UroToday.com) - Cisplatin-based chemotherapy is the first-line agent for metastatic urothelial carcinoma (UC).
Login to read more...

ASCO 2009 - A Phase II Study of Sunitinib on a Continuous Dosing Schedule in Patients with Relapsed or Refractory Urothelial Carcinoma - Session Highlights
Tuesday, 02 June 2009
ORLANDO, FL, USA (UroToday.com) - Sunitinib has demonstrated activity as a second-line agent for patients with advanced urothelial carcinoma (UC) when administered on a 4 week on, 2 week off schedule.
Login to read more...

Purse-string Technique for Laparoscopic Excision of a Bladder Mucosal Cuff in Patients with Transitional Cell Carcinoma of the Upper Urinary Tract: Initial Report with Intermediate Follow-Up - Abstract
Tuesday, 02 June 2009
Urology and Nephrology centre, Mansoura University, Mansoura, Egypt.
read more

Management of the First Recurrence of T1G3 Bladder Cancer: Does Intravesical Chemotherapy Deserve a Chance? - Abstract
Tuesday, 02 June 2009
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
read more

Peroxisome Proliferator-Activated Receptor Gamma in Bladder Cancer: A Promising Therapeutic Target - Abstract
Tuesday, 02 June 2009
Division of Urology, McGill University Health Center, Montreal, Canada.
read more

Multimedia Presentation - Superficial Bladder Cancer - TCC
Tuesday, 02 June 2009
BERKELEY, CA (UroToday.com) - An update on superficial bladder cancer by Barry Stein, MD.
Login to read more...

BJUI Mini Reviews - Neuroendocrine Tumours of the Urinary System and Male Genital Organs: Clinical Significance
Monday, 01 June 2009
The aim of this review is to discuss the clinical features, origins, morphological and immunophenotypic proﬁles, and prognosis of neuroendocrine tumours of the urinary system and male genital organs.
Login to read more...

Optimal Timing of Radical Cystectomy for Patients with T1 Bladder Cancer - Abstract
Monday, 01 June 2009
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.
read more

Quantitative Exposure to Metalworking Fluids and Bladder Cancer Incidence in a Cohort of Autoworkers - Abstract
Monday, 01 June 2009
Occupations with mineral oil exposure have been associated with bladder cancer in population-based case-control studies.
read more

Summaries of Clinical Studies Relating to Veterans and Bladder Cancer
Monday, 01 June 2009
Login to read more...

Veterans Health Administration Office of Patient Care Services Technology Assessment Program
Monday, 01 June 2009
Login to read more...

Beyond the Abstract - Molecular Analyte Profiling of the Early Events and Tissue Conditioning Following Intravesical Bacillus Calmette-Guerin Therapy in Patients With Superficial Bladder Cancer
Friday, 29 May 2009
BERKELEY, CA (UroToday.com) - Since the work of Morales et al. in 1976, BCG therapy has been the standard of care for superficial transitional cell carcinoma.
Login to read more...

Synchronous Metastatic Renal Cell Carcinoma to the Genitourinary Tract: Two Rare Case Reports and a Review of the Literature - Abstract
Monday, 25 May 2009
Division of Urology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
read more

Focus on Bladder Cancer

Focus on Bladder Cancer condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.

Exclusive!
Interview with Barry Stein, MD on Clinical Practice Experience with NMP22

Podcast - San Francisco Firefighters and Bladder Cancer Screening

Synergistic potentiation of interferon activity with maitake mushroom D-fraction on bladder cancer cells

- by Sensuke Konno, PhD, et al.

Non-invasive methods to detect schistosome-based bladder cancer: is the association sufficient for epidemiological use?

- by Clive Shiff, MD and Robert W. Veltri, MD

Urinary Bladder Cancer: Diffusion-Weighted MR Imaging--Accuracy for Diagnosing T Stage and Estimating Histologic Grade

- by Mitsuru Takeuchi, MD

Clinical Outcome of Chemoradiotherapy for T1G3 Bladder Cancer

- by Masaharu Inoue, MD, et al.

External Beam Radiation Therapy Followed by Interstitial Radiotherapy with Iridium-192 for Solitary Bladder Tumours: Results of 111 Treated Patients

- by lze E.W. van Onna, MD

Bladder Tumor Markers: From Hematuria to Molecular Diagnostics - Where Do We Stand?

- by Samir Shirodkar, MD

Familial and Genetic Risk of Transitional Cell Carcinoma of the Urinary Tract

- by Christine M. Mueller, DO, et al.

Bladder-Sparing Therapy for Muscle-Infiltrating Bladder Cancer

- by Paolo Emiliozzi, MD

Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation?

- by Christopher P. Evans, MD, FACS

The Novel Use of Intravesical Docetaxel for the Treatment of Non-Muscle Invasive Bladder Cancer Refractory to BCG Therapy: A Single Institution Experience

- by David P. Wood, Jr. MD

Predictive Value of Telomerase Reverse Transcriptase Expression in Patients with High Risk Superficial Bladder Cancer Treated with Adjuvant BCG Immunotherapy

- by David P. Wood, Jr. MD

Prognostic Significance of Nondiagnostic Molecular Changes in Urine Detected by UroVysion Fluorescence In Situ Hybridization During Surveillance for Bladder Cancer

- by David P. Wood, Jr. MD

Cultured Milk, Yogurt, and Dairy Intake in Relation to Bladder Cancer Risk in a Prospective Study of Swedish Women and Men

- by David P. Wood, Jr. MD

Adjuvant Methotrexate, Vinblastine, Adriamycin, and Cisplatin Chemotherapy has Potential to Prevent Recurrence of Bladder Tumors After Surgical Removal of Upper Urinary Tract Transitional Cell Carcinoma

- by David P. Wood, Jr. MD

Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness

- by Ricardo Sånchez-Ortiz, MD - Editor's Pick

Laparoscopic Radical Cystectomy for Cancer: Oncological Outcomes at up to 5 years

- by David P. Wood, Jr. MD - Editor's Pick

Safety and Efficacy of Ofloxacin on Bacillus Calmette-Guerin Induced Toxicity in Patients with Superficial Bladder Cancer

- by Yassine Nouira, MD, et al.

Efficacy of Bacillus Calmette-Guerin (BCG) Therapy and Cauterization of the Tumor Versus BCG Therapy Without Cauterization for Superficial Bladder Cancer

- by Siavash Falahatkar, MD, et al.

A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria

- by Louis S. Liou, MD, et al.

Utilization of the NMP22® BladderChek® Urine Test as an Adjunct to Atypical Cytology in the Detection of Bladder Cancer Recurrence

- by Ravi Munver, MD, et al.

Long Term Clinical Outcome of a Phase I Trial of Intravesical Docetaxel in the Management of Superficial Bladder Cancer Refractory to Standard Intravesical Therapy

- by Mitchell C. Benson, MD, and James M McKiernan, MD

Investigation of Publication Bias Using the Model of p53 Accumulation in Bladder Cancer

- by Peter J. Goebell, MD, et al.

Should All Patients Receive Single Chemotherapeutic Agent Instillation after Bladder Tumour Resection?

Therapeutic Options in the Management of Intermediate-Risk Nonmuscle-Invasive Bladder Cancer

Two Centuries of Cystoscopy: The Development of Imaging, Instrumentation and Synergistic Technologies

Bladder Cancer and the Aluminium Industry: A Review

Invasive T1 Bladder Cancer: Indications and Rationale for Radical Cystectomy

Bladder Cancer Screening

Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay

- by Mark S. Soloway, MD

Improving the Diagnosis of Bladder Cancer -Combining Cystoscopy with a Physician's Office Tumor Marker Test

- CME Training Program

Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay
- Barry Stein, MD on Improved Detection of Bladder Cancer in Diagnosis

Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis?
- Yair Lotan, MD on Screening for Bladder Cancer

Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer
- Giora Katz, MD Reports on Increased Risk for Bladder Cancer

Utility of NMP22 BladderCheck Point-Of-Care Assay In Evaluation Of Hematuria: A Multicenter Study
- Giora Katz, MD on the Utility of NMP22 Bladdercheck

Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay
- H. Barton Grossman, MD & the NMP22 Clinical Investigation Group

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Session Highlight by Thomas J. Guzzo, MD, MPH from the AUA Mid-Atlantic Section 67th Annual Meeting

Management of non-muscle invasive bladder cancer: Use of 2007 AUA guidelines
- Multimedia Lecture by Muhammad Choudhury, MD from the AUA NY Section 107th Annual Meeting

Improving survival for patients with bladder cancer
- Multimedia Lecture by Ralph de Vere White, MD from the AUA NY Section 107th Annual Meeting

Fluorescence cystoscopy for detection of initial and recurrent bladder cancer
- Multimedia Lecture by Ihor Sawczuk, MD from the AUA NY Section 107th Annual Meeting

Early cystectomy for T1 bladder cancer
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Treatment of muscle invasive bladder cancer in elderly
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Robotic extended pelvic lymphadenectomy for bladder cancer: Initial experience with greater nodal yield
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

Open versus robot-assisted radical cystectomy: Comparison of early outcomes and cost
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Presented by Stephen A. Boorjian, MD

American Society of Clinical Oncology (ASCO) 2009 Annual Meeting
- View Bladder Cancer Session Highlights
American Urological Association (AUA) 2009 Annual Meeting
- View Bladder Cancer Session Highlights from the AUA 2009 Annual Meeting
10 Tips for Non-Muscle Invasive Bladder Cancer
- Lecture presented at WUF 2009 by David P. Wood, Jr., MD

Society of Urologic Oncology (SUO) 9th Annual Winter Meeting
- View Bladder Cancer Session Highlights

Robot Assisted Radical Cystectomy: Is it Ready for Prime Time?
- Session Highlight from AUA Western Section 2008

Bladder Cancer Cytology and Markers in Diagnosis and Assessment
- Presentation from the 2008 AUA NY Meeting

Re-Staging Transurethral Resection: Who Benefits?
- Slide Presentation from the 2008 AUA NY Section Meeting

Non-Muscle Invasive Transitional Cell Carcinoma
- Slide Presentation from the 2008 Masters in Urology Conference
American Society of Clinical Oncology 44th Annual Meeting
- Bladder Cancer Abstracts

The American Urological Association 2008 Annual Meeting
- Bladder Cancer Session Highlights

Engineering and Urology Society 23rd Annual Meeting
- Bladder Cancer Abstracts